During the past decade, Gastroenterologie am Bayerischen Platz conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastroenterologie am Bayerischen Platz" #1 sponsor was "Celgene" with 3 trials, followed by "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored, "Alimentiv Inc." with 1 trials sponsored, "Applied Molecular Transport" with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastroenterologie am Bayerischen Platz" #1 collaborator was "FUJIFILM Deutschland, Branch office of FUJIFILM Europe GmbH" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Norgine" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Gastroenterologie am Bayerischen Platz" are "Crohn Disease" (4 trials), "Crohn's Disease" (3 trials), "Adenoma Detection Rate" (2 trials), "Colonoscopic Control After Polypectomy" (1 trials) and "Inflammatory Bowel Diseases" (1 trials). Many other conditions were trialed in "Gastroenterologie am Bayerischen Platz" in a lesser frequency.

Most popular intervention types in "Gastroenterologie am Bayerischen Platz" are "Drug" (9 trials), "Other" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Placebo" (3 trials), "AMT-101 (oral)-Dose A" (1 trials), "AMT-101 (oral)-Dose B" (1 trials) and "CT-P13" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterologie am Bayerischen Platz" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Gastroenterologie am Bayerischen Platz". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Gastroenterologie am Bayerischen Platz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterologie am Bayerischen Platz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".